siRNA treatment reduces triglycerides in clients with unusual problem

.RESEARCH FEATURE.19 September 2024.

Plozasiran lowered triglyceride levels by 80% and lowered the threat of pancreatitis in people along with chronic chylomicronemia, along with or without a genetic medical diagnosis.